Exercise during hemodialysis does not affect the phenotype or pro-thrombotic nature of microparticles but alters their pro-inflammatory function by Naomi Martin (4673296) et al.
ORIGINAL RESEARCH
Exercise during hemodialysis does not affect the phenotype
or prothrombotic nature of microparticles but alters their
proinflammatory function
Naomi Martin1,2, Alice C. Smith2, Maurice R. Dungey1,2, Hannah M. L. Young2, James O. Burton2 &
Nicolette C. Bishop1
1 National Centre for Sport and Exercise Medicine, School of Sport, Exercise and Health Sciences, Loughborough University, Leicestershire,
United Kingdom
2 Leicester Kidney Lifestyle Team, Department of Infection, Immunity & Inflammation, University of Leicester and John Walls Renal Unit,
University Hospitals of Leicester NHS Trust, Leicestershire, United Kingdom
Keywords
Cardiovascular disease, hemodialysis,
inflammation, kidney, microparticles.
Correspondence
Nicolette C. Bishop, National Centre for
Sport and Exercise Medicine, School of Sport,
Exercise and Health Sciences, Loughborough
University, Leicestershire LE11 3TU, UK.
Tel: + 44 1509 226385
E-mail: n.c.bishop@lboro.ac.uk
Funding Information
The research was supported by the
Stoneygate Trust and the National Institute
for Health Research (NIHR) Leicester
Biomedical Research Centre.
Received: 12 July 2018; Accepted: 19 July
2018
doi: 10.14814/phy2.13825
Physiol Rep, 6 (19), 2018, e13825,
https://doi.org/10.14814/phy2.13825
Abstract
Hemodialysis patients have dysfunctional immune systems, chronic inflamma-
tion and comorbidity-associated risks of cardiovascular disease (CVD) and
infection. Microparticles are biologically active nanovesicles shed from acti-
vated endothelial cells, immune cells, and platelets; they are elevated in
hemodialysis patients and are associated with chronic inflammation and pre-
dictive of CVD mortality in this group. Exercise is advocated in hemodialysis
to improve cardiovascular health yet acute exercise induces an increase in cir-
culating microparticles in healthy populations. Therefore, this study aimed to
assess acute effect of intradialytic exercise (IDE) on microparticle number and
phenotype, and their ability to induce endothelial cell reactive oxygen species
(ROS) in vitro. Eleven patients were studied during a routine hemodialysis
session and one where they exercised in a randomized cross-over design.
Microparticle number increased during hemodialysis (2064–7071 microparti-
cles/lL, P < 0.001) as did phosphatidylserine+ (P < 0.05), platelet-derived
(P < 0.01) and percentage procoagulant neutrophil-derived microparticles
(P < 0.05), but this was not affected by IDE. However, microparticles col-
lected immediately and 60 min after IDE (but not later) induced greater ROS
generation from cultured endothelial cells (P < 0.05), suggesting a transient
proinflammatory event. In summary IDE does not further increase prothrom-
botic microparticle numbers that occurs during hemodialysis. However, given
acute proinflammatory responses to exercise stimulate an adaptation toward a
circulating anti-inflammatory environment, microparticle-induced transient
increases of endothelial cell ROS in vitro with IDE may indicate the potential
for a longer-term anti-inflammatory adaptive effect. These findings provide a
crucial evidence base for future studies of microparticles responses to IDE in
view of the exceptionally high risk of CVD in these patients.
Introduction
Chronic kidney disease (CKD) affects approximately 10%
of the world’s population (Eckardt et al. 2013). Patients
with end-stage renal disease have a dysfunctional immune
system that is paradoxically chronically activated and aner-
gic (Betjes 2013); this manifests as systemic inflammation
associated with an increased risk of atherosclerosis,
cardiovascular disease (CVD), and cachexia (Stenvinkel
2010; Heine et al. 2012). End-stage renal disease patients
are also immunologically vulnerable (Kurts et al. 2013)
and have higher risk and greater severity of infections and
associated tissue injury (Dalrymple and Go 2008). As
such, the progression of CKD is in part mediated by the
immune system (Kurts et al. 2013). Hemodialysis (HD)
itself is associated with further increased mortality,
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aggravated by cardiac injury induced by intradialytic
hypotension (Shoji et al. 2004), myocardial stunning
(Burton et al. 2009), immune activation aggravated by
endotoxin influx (Kurts et al. 2013) and biomaterial-
induced complement activation (Nilsson et al. 2007).
Patients with kidney disease have an altered immune
and inflammatory profile, possibly due to the uremic
environment (Girndt et al. 2001), with increased proin-
flammatory T-cells, monocytes, monocyte and neutrophil
Toll-Like Receptor 4 activity and activated platelet aggre-
gates (Ashman et al. 2003; Gollapudi et al. 2010; Kurts
et al. 2013). This is associated with elevated concentra-
tions of circulating proinflammatory cytokines including
TNFa, IL-6 and the acute phase reactant, C-reactive pro-
tein (Girndt et al. 1995; Costa et al. 2008). Chronic
inflammation increases incrementally with CKD progres-
sion (Kaysen 2014) and is intrinsically linked to the high
risk of mortality and morbidity from CVD in these
patients (Stenvinkel 2010). In CKD, microparticles (MP)
have proinflammatory actions (Puddu et al. 2010) and
have been associated with endothelial damage, increased
risk for calcification, anemia, and thrombosis (Gao et al.
2015; Erdbr€ugger and Li 2016), with endothelial derived
MP collected 72 h after last dialysis reported to indepen-
dently predict all-cause and CVD mortality in stable HD
patients (Amabile et al. 2012). MP are shed from acti-
vated or apoptotic sources including immune cells plate-
lets and endothelial cells (Boulanger et al. 2007), with
their actions depending on their cellular origin (Barteneva
et al. 2013). These intact circulating membrane nanovesi-
cles range in size from 100 to 1000 nm and are composed
of plasma membrane and the cytoplasmic contents of
their parent cell (Morel et al. 2011). MP act as systemic
signaling vehicles and their inflammatory actions include
inducing leukocyte aggregation (Forlow et al. 2000),
chemotaxis (Barry et al. 1998) and the release of cytoki-
nes (Puddu et al. 2010). Indeed, MP can transport and
transfer proteins such as tissue factor, a major initiator of
blood coagulation, contributing to endothelial dysfunc-
tion (Scholz et al. 2002). The actions of MP therefore
represent a connection between chronic inflammation
and CVD in CKD.
Lower levels of physical activity are a risk factor for
CVD yet within the HD population patients are fre-
quently inactive (Johansen et al. 2000) and this is associ-
ated with a risk mortality of similar magnitude to that of
other well-established risk factors, such as a one-point
reduction in serum albumin concentration (O’Hare et al.
2003). A recent Cochrane review reported a plethora of
benefits of regular exercise for this population, including
improvements to cardiovascular health (Heiwe and Jacob-
son 2014). The so-called “anti-inflammatory” effect of
regular exercise is thought to play a key role through
various different mechanisms that centre on a chronic
adaptive response to repeated transient proinflammatory
events during and following acute exercise sessions (Glee-
son et al. 2011). These include reducing visceral adipose
tissue mass and associated inflammatory cytokine release,
stimulating transient acute proinflammatory cytokine
release from muscle, leading to a counteractive, longer
lasting release of anti-inflammatory mediators and move-
ment from a proinflammatory toward an anti-inflamma-
tory profile of immune cell phenotypes (Gleeson et al.
2011). Indeed, we have recently reported favorable
changes in inflammatory leukocyte phenotype with a
reduction in monocytes with a proinflammatory pheno-
type in patients after 6 months of moderate intensity IDE
compared with non-exercising HD patients (Dungey et al.
2017). This is arguably as an adaptive response to regular
exercise given our earlier observation of acute elevations
in proinflammatory monocyte phenotypes in response to
a single IDE session of the same intensity (Dungey et al.
2015). Acute exercise is also known to induce an increase
in circulating MP (Fr€uhbeis et al. 2015) and in healthy
populations, transient increases in, platelet-, monocyte-,
and EC-derived MP (Lansford et al. 2016) have been
reported following acute moderate-vigorous exercise.
These acute elevations are thought to be necessary to
stimulate an anti-inflammatory adaptation with repeated
exercise sessions as lower numbers of EC MP are reported
in healthy individuals in response to long-term aerobic
training (Kim et al. 2015). Therefore, the aim of this
study was to assess the acute effect of IDE on the total
number, cellular origin, prothrombotic phenotype and
ROS inducing ability of circulating MP. We hypothesized
that an acute bout of IDE would induce a greater MP
response compared to routine HD.
Materials and Methods
This novel investigation used samples collected from a
subgroup of patients recruited to our previously pub-
lished study (Dungey et al. 2015). While the trial protocol
is the same, the analyses and data presented here are
novel and have not been previously published.
Patients
Eleven patients were recruited from a satellite unit of
University Hospitals of Leicester NHS Trust. In this ran-
domized crossover study, patients were studied during a
routine HD session and also one where they completed
exercise. Exclusion criteria were: age < 18 years, lower
limb vascular access, cardiovascular event in the last
3 months, severe heart failure, severe chronic obstructive
pulmonary disease, acute liver disease, uncontrolled
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diabetes mellitus, severe lower limb orthopedic problems,
severe lower limb neuromuscular disease, clinically overt
infection in the last 6 weeks, pregnancy, insufficient com-
mand of English to understand the patient information
sheet and give informed consent. All patients had one or
more significant non-renal comorbidity reported in their
medical history. Specifically, 2 of the 11 patients had dia-
betes mellitus (18%), 9 were diagnosed with hypertension
(81%), and 5 were diagnosed with heart disease (54%).
All patients used polysulfone high-flux dialyzers. The dia-
lysate, dialyzer, needle size and dialysis duration and pre-
scriptions were unchanged between study days. The study
received approval from the NHS Research Ethics Com-
mittee (ref. 10/H0406/36), and all patients gave written
informed consent to participate. Patient characteristics are
represented in Table 1.
Exercise session
The exercise session has been described in detail previ-
ously (Dungey et al. 2015). Briefly, patients participated
in 2 trial arms, separated by a week and carried out on
the same day each week. For the exercise arm, 60 min
into their HD treatment patients performed a 5 min
warm-up followed by a 30 min bout of IDE using a spe-
cially designed cycle ergometer (Letto series; Reck, Ger-
many). Patients cycled at self-selected gears at a rating of
perceived exertion of “somewhat hard” (Borg 1973).
Patients routinely took part in an exercise program for at
least 3 months prior to this study therefore the study here
represents the usual effects of regular IDE for these
patients. During the control non-exercising arm of the
study patients rested throughout HD.
Phlebotomy and microparticle isolation
To investigate the acute effects of exercise, blood samples
were taken from the HD lines pre-exercise (60 min of
HD), immediately after exercise (post-exercise, 100 min
of HD), 1 h post-exercise (160 min of HD, and at the
end of HD (240 min of HD). In the non-exercising con-
trol sessions bloods were taken at equivalent times of
HD. Blood was drawn using a dry syringe and immedi-
ately aliquoted into a trisodium citrate pretreated
monovette (Sarstedt AG, N€umbrecht, Germany). Platelet-
poor plasma was prepared from blood samples following
two centrifugation steps of 2500g for 20 min at 4°C, and
then stored in 250 lL aliquots at 80°C until use. MP
in cell-free plasma were prepared according to Jy et al.
(2004).
Flow cytometry
Annexin V (AnV) expression was used to detect phos-
phatidylserine expression on MP, considered to be pro-
thrombotic (Owens and Mackman 2011). Aliquots of MP
were incubated alone, with Annexin V-fluorescein isothio-
cyanate (AnV-FITC) (BD Biosciences, Oxford, UK) as a
marker of phosphatidylserine expression, and buffer A
(10 mmol/L HEPES, 140 mmol/L NaCl, 2.5 mmol/L
CaCl2, pH 7.4) or with AnV-FITC and a calcium-free
control buffer B (10 mmol/L HEPES, 140 mmol/L NaCl,
pH 7.4) in the dark for 25 min at RT. Buffer A was
added to MP alone, or AnV-stained MP, while control
AnV staining was assessed with by adding buffer B to
AnV-stained MP. Phenotypic labeling was performed with
the following mouse anti-human phycoerythrin(PE)-
labeled antibodies to specific cell surface markers: platelet
CD42b, endothelial cell CD144, tissue factor CD142, neu-
trophil CD66b, monocyte CD14, or appropriate isotype
control antibodies (all BD Biosciences, Oxford, UK). MP
were also dual-labeled with phenotyping antibodies as
above plus AnV-FITC. All antibody incubations were car-
ried out as described above and MP were resuspended in
buffer A. MP were enumerated using Flow-Count Fluoro-
spheresTM (Beckman Coulter, High Wycombe, UK). All
flow cytometric acquisition was done using a FACSCanto
Table 1. Patients’ characteristics.
Age (y) 59  10
Sex (n)
Male/Female 7/4
Ethnicity (n)
White British 4 (36%)
Indian 7 (64%)
Height (cm) 166  9
Dry weight (kg) 80.2  19.2
BMI (kg/m2) 28.8  6.8
Hemodialysis vintage (y) 3.62 (0.94–3.82)
Access
AVF 9 (82%)
Catheter 2 (12%)
Primary disease (n) Glomerulonephritis (3)
Cystic/Poly (2)
Diabetes (1)
Pyelonephritis (1)
Uncertain (3)
Other (1)
Number of co-morbidities 4  2 (range 1–7)
Number of medications 12  4 (range 4–16)
1Systolic blood pressure (mmHg) 122 (111–145)
1Diastolic blood pressure (mmHg) 64 (56–71)
Data are mean  standard deviation, median (interquartile range),
or n (%).
1
Blood pressure variables are based on a 3-day average taken
before (and not including) the first trial day.
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II and all analysis was carried out using FACSDivaTM soft-
ware (both BD Biosciences, Oxford, UK). MP were
acquired using a gating defined by size-calibrated fluores-
cent MegamixTM beads according to the manufacturer’s
instructions (BioCytex, Marseille, France) and according
to a standardized calibrated-bead strategy (Robert et al.
2008). Examples of flow cytometric profiles are shown in
Figure 1. All samples were acquired using the slowest flow
rate for a fixed time period of 120 seconds.
MP-induced reactive oxygen species
generation
EA.hy926 EC lines were maintained according to the
manufacturer’s instructions; they were cultured in DMEM
supplemented with 10% (v/v) heat-inactivated fetal calf
serum, 2 mmol/L L-glutamine, 100 U/mL penicillin,
100 lg/mL streptomycin (all Life Technologies, Warring-
ton, UK) and maintained at 37°C in a humidified 5%
CO2 atmosphere. EA.hy926 cells were seeded onto black
96-well plates (Perkin Elmer, Seer Green, UK) at a density
of 2.5 9 104 cells/well. The following day the medium
was removed and cells were loaded with 5 lmol/L
dichloro-dihydro-fluorescein diacetate (DCFH-DA)
(Sigma, Gillingham, UK) at a final concentration of
10 lg/mL in medium for 15 min at 37°C in the dark
before the addition of 25 lL MP (prepared and enumer-
ated as above), control buffers or medium (Sigma,
Gillingham, UK). Fluorescence was measured at 529 nm
immediately, every 15 min for 2 h at 37°C and finally
after a 20 h incubation at 37°C in a humidified 5% CO2
atmosphere, using a VarioskanTM Flash Multimode Reader
(Thermo Fisher Scientific, Loughborough, UK). Each
treatment was carried out in duplicate.
Statistics
Treatment conditions and baseline differences between
arms were compared using paired t-tests or Wilcoxon
signed-ranks tests where applicable. Two-factor repeated
measures ANOVA was used to analyze data: trial arm
(exercise vs. control) 9 time. Where data were
non-normally distributed (Shapiro-Wilk) ANOVA
was performed on the logarithmic transformation of
the data and reported in original form. If the omnibus
test found a significant effect post hoc paired t-tests
and repeated contrasts were used and adjusted for mul-
tiple comparisons using the Holm-Bonferroni method
(Holm 1979). Statistical analysis was performed on Sta-
tistical Package for Social Sciences (SPSS v.22, IBM,
New York). Data are presented as mean  standard
deviation or median (interquartile range) as described.
Statistical significance was accepted at P < 0.05.
Results
Exercise and hemodialysis
All 11 recruited patients successfully completed 30 min of
cycling starting 60 min into HD on the exercise trial. The
mean power output was measured as 22.5  7.3 W. Pre
HD body mass, ultrafiltration goal and pump speed did
not differ between exercise and resting trials (Table 2).
No adverse events were reported.
Evaluation of the effects of hemodialysis
and IDE on total and prothrombotic
microparticles
We observed a significant increase in the number of MP
over the course of HD (main effect of HD, P < 0.001)
(Fig. 2) with a ~4 fold increase from 60 min into HD
compared to the end of HD. There was no effect of IDE.
The overall number (Fig. 3A), but not % (Fig. 3B), of
MP expressing phosphatidylserine increased significantly
over the course of HD (main effect of HD, P < 0.05),
with increases seen in 22 out of the 26 HD sessions
observed. Over the same time there was a decrease
(P = 0.066) in % (but not number) of circulating MP
expressing tissue factor (Fig. 3C). Again IDE had no effect
on these responses.
Evaluation of the effects of hemodialysis
and IDE on the cellular origin of
microparticles
There was a significant increase in the number of platelet-
derived CD42b+MP by the end of HD (main effect of HD,
P < 0.001, Table 3). There were no other significant changes
in the numbers of MP derived from the other cellular origins
studied, but there was a trend (main effect of HD, P = 0.08)
for an increase in monocyte-derived CD14 + MP over the
course of HD (Table 3). IDE had no effect on these
responses. The % procoagulant phosphatidylserine+ MP
derived from platelets (Fig. 4A), EC (data not shown) and
monocytes (Fig. 4B) were unaffected by HD or exercise.
However, % neutrophil-derived phosphatidylser-
ine+CD66b+MP decreased between 100 and 160 min of HD
(43.3  28.4% to 24.2  25.4%), main effect of HD,
P < 0.05; Fig. 4C). Again IDE had no effect on this response.
Evaluation of ROS-inducing effects of
microparticles from dialyzing and
intradialytic exercising patients
The ROS-inducing capabilities of MP taken from patients
while exercising and at rest during HD were investigated
2018 | Vol. 6 | Iss. 19 | e13825
Page 4
ª 2018 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society.
Intradialytic Exercise and Microparticle N. Martin et al.
to provide insight into their function and potential
involvement in pathophysiology. MP collected from exer-
cising patients immediately after their IDE session
(Fig. 5A) had significantly greater ability to induce ROS
after 120 min incubation with EC compared to MP col-
lected at the same time (100 min into HD) when resting
(delta change of 2.82  3.03 compared to 1.68  5.42
DCFHDA fluorescence units per 1000 MP; P < 0.05).
This increased ROS induction in EC was still evident in
MP from patients 60 min after their exercise session
(Fig. 5B) compared to MP taken at the same time at rest
(delta change of 3.72  4.04 compared to 5.99  3.94
DCFHDA fluorescence units per 1000 MP; P < 0.05).
There were no differences between trial arms at the end
of HD.
Discussion
This is the first study to comprehensively characterize the
acute response of circulating MP to IDE during HD and
to investigate the ability of these circulating MP to induce
EC ROS in vitro. Our findings suggest that IDE at an
intensity that can be sustained for 30 min does not exac-
erbate the effects of HD in increasing the number and
phenotype of prothrombotic circulating MP. However,
MP collected after IDE induced greater ROS production
from cultured EC, suggesting an acute, short-lived proin-
flammatory response; this could indicate the potential for
chronic anti-inflammatory adaptation with regular IDE.
Given the association between MP, inflammation and
endothelial dysfunction in CKD (Erdbr€ugger and Li
2016), the link between MP and cardiovascular mortality
(Amabile et al. 2012) in HD patients, and the known
anti-inflammatory effects of exercise (Gleeson et al. 2011)
these findings provide new insight into the effect of the
HD process on cardiovascular risk in end stage renal dis-
ease and the impact of IDE on this risk.
To the best of our knowledge, there are no other stud-
ies to date reporting enumeration of, or changes in, the
total number of circulating MP during HD. Previous
work by our group looking at total numbers of circulat-
ing MP in HD patients did not observe numbers during
Figure 1. Examples of flow cytometric analysis of microparticles. Representative graphs from cytofluorometric analysis of MP in platelet-free
plasma from non-exercising CKD patient undergoing HD. (A) Construction of MP gating region using Megamix submicrometer beads (based on
(Puddu et al. 2010)) and MP enumeration using Flow-Count beads. (B) Determination of phosphatidylserine/AnnexinV+ MP. Representative
phenotyping flow cytometric analysis of MP, comparing positively stained gated MP were determined by comparison with isotype control
staining (C). CD42b+ (platelet-derived) MP events from samples taken 60 min into HD (D) to those the end of the HD session (E).
Table 2. Hemodialysis treatment variables on exercise and control
trial arms.
Exercise Control P value
Pre-HD weight (kg) 81.4  19.2 81.5  19.5 0.736
Ultrafiltration goal (L) 1.62  0.63 1.56  0.74 0.545
Pump speed (mL/min) 324  45 324  45 1.000
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the HD process itself (Burton et al. 2013). In addition,
this study used Nanoparticle-tracking analysis to enumer-
ate MP without any surface marker detection. We used
flow cytometry with MP fluorescent intensity using size-
calibrated fluorescent beads is as a threshold for particle
detection. This approach offers better separation from
background noise, is less likely affected by aggregation of
particles and might detect particles as low as 100–200 nm
(Erdbr€ugger and Li 2016) and although one technique
was used here to enumerate and analyze MP, recent pub-
lications assert that flow cytometry remains the most suit-
able method for determining the cellular origin on MP
(Maas et al. 2015; Erdbr€ugger and Li 2016; Cointe et al.
2017). It was not possible for us to phenotype MP in this
study using Western blotting due to the small sample vol-
umes obtained (Pospichalova et al. 2015). A recent study
highlighting the limitations of both Nanosight particle
tracking analysis and tunable resistive pulse sensing (Maas
et al. 2015) suggests that flow cytometry is the most sen-
sitive and accurate method for enumeration of MP.
Therefore, flow cytometry is the most appropriate method
for the phenotypic enumeration analyses required to
address the hypothesis of this study, and no other single
method would provide such comprehensive information.
Contact of blood with foreign materials and vascular
shear stress during HD causes activation of immune cells,
the complement system, cytokine production and release
and oxidative stress (Amore and Coppo 2002) despite the
dilution of uremic toxins. Subjecting blood to conditions
simulating flow itself induces increases in MP numbers
in vitro (Holtom et al. 2011), while adding uremic
plasma (Dursun et al. 2009) or uremic toxins (Faure
et al. 2006) to cultured EC cell lines induces endothelial
dysfunction and MP release in vitro. Thus, it is of no sur-
prise that we observed an acute increase in total MP
numbers, although exercise performance had no effect,
possibly due to the relatively low workload that patients
were able to perform here. This is in line with our previ-
ous findings that the IDE used here has little impact on
HD-induced neutrophil activation and inflammatory
cytokine release (Dungey et al. 2015). Other studies inves-
tigating the effects of exercise on MP have studied healthy
younger subjects and used moderate-vigorous incremental
exercise protocols (Chaar et al. 2011; Wahl et al. 2014;
Fr€uhbeis et al. 2015) with exercise beginning at ~100 W.
This far exceeds the capabilities of the patients studied
here (average 22 W). Therefore, although the protocol
used here did not induce many exercise-related changes
in numbers of MP, ours was a pragmatic approach geared
toward assessing the responses to the exercise capabilities
of our patient population.
Changes in circulating prothrombotic MP were
observed over the course of HD, but again no differences
were detected between the exercising or resting study
arms. The number of phosphatidylserine +MP increased
over the course of HD yet the number of MP expressing
tissue factor did not change, although there was a
decrease in the proportion of these. Although phos-
phatidylserine and tissue factor are both considered pro-
thrombotic molecules, recent research suggests that they
have different roles in the coagulation process (Spronk
et al. 2014), with phosphatidylserine considered a potent
inducer of cell-surface tissue factor conversion into its
prothrombotic decrypted state (Rao et al. 2012). There-
fore, the increase in phosphatidylserine+ MP may have
subsequent prothrombotic impacts beyond the observa-
tion period of this study.
The overall percentage of phosphatidylserine+MP
remained unchanged both over the course of HD and
during each arm of the study but, at an average of 4%
phosphatidylserine+MP of the total MP population, was
considerably lower than the 90% that has been previously
reported in HD patients when not on dialysis (Trappen-
burg et al. 2012). Our values may reflect clearance during
HD, but perhaps more likely to reflect methodological
and definition variations known to cause discrepancies in
MP numbers and indeed phosphatidylserine expression in
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Figure 2. Total numbers of microparticles over the course of HD in
exercising and non-exercising CKD patients. Patients on HD rested
(open symbols) or exercised (closed symbols). MP were isolated,
then analyzed and enumerated using flow cytometry, from samples
taken 60 min into HD, immediately following exercise (or
equivalent time in control group), 60 min after exercise (equivalent
to 160 min into dialysis for control group) and at the end of HD.
Total numbers of MP had increased significantly by the end of HD
compared to both 60 min and 100 min (main effect for HD,
**P < 0.01 for both) into HD. The numbers of MP at 160 min into
HD were also significantly greater than those observed 60 min into
HD (*P < 0.05). All of these observed increases were irrespective of
IDE. All n = 10.
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earlier studies (Ayers et al. 2011; Erdbr€ugger and Li
2016). Values of around 11% phosphatidylserine+MP
have been reported in healthy males (Nielsen et al. 2014).
AnV is commonly used, as in this study, to detect surface
expression of its phospholipid ligand, phosphatidylserine
but it is not clear how much PS is externalized on MP
and not all MP bind AnV (Erdbr€ugger and Li 2016). AnV
and phosphatidylserine expression alone should not be
used as a definitive marker for all MP, but should be
applied to consider populations of both phosphatidylser-
ine+ and phosphatidylserine MP. Without consistency
in definitions comparisons between studies remain
difficult.
Increased numbers of MP derived from platelets and
EC are known to be associated with risk factors for CVD
with EC-derived MP predictive of all cause and CVD
mortality in stable HD patients (Amabile et al. 2012). We
found an increase in platelet-derived CD42b+MP over the
course of HD, irrespective of whether exercise had taken
place or not. However, we found no changes in phos-
phatidylserine+CD42b+MP. Platelet-derived CD41 + MP
(Daniel et al. 2006; Faure et al. 2006) and CD42 + MP
(Burton et al. 2013) have been shown to be increased in
number in both nondialysis CKD and HD patients com-
pared to healthy controls, and differences may be again
related to the use of phosphatidylserine expression to
define MP (Erdbr€ugger and Li 2016).
We detected extremely low, or absent, circulating EC-
derived CD144 + MP in patients when resting or exercis-
ing during HD. Other investigations report decreases in
CD41-CD31 + MP (Boulanger and Dignat-George 2011)
and CD144 + MP (Trappenburg et al. 2012), or no
changes in either CD144 + MP or CD146 + MP (Faure
et al. 2006) following an HD session. CD144 and CD105
are the only constitutive markers of EC which are not
found on other cell types (Latham et al. 2015) and
although a variety of endothelial markers are used by
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Figure 3. Procoagulant microparticles over the course of HD in
exercising and non-exercising CKD patients. Patients on HD rested
(open symbols) or exercised (closed symbols). MP isolated from
samples were taken 60 min into HD, immediately following exercise
(or equivalent time in control group), 60 min after exercise
(equivalent to 160 min into dialysis for control group) and at the
end of HD were labeled with AnnexinV which binds to
phosphatidylserine, or anti-CD142, and analyzed using flow
cytometry. There was a significant increase in the number of
phosphatidylserine-positive MP (A) in both groups from 60 min into
HD compared to at the end of HD (main effect of HD, *P < 0.05),
but there was no significant change in the percentage of MP
stained with AnV (B) over the course of HD or any differences
between exercising or non-exercising groups. Number of CD142+
tissue factor expressing MP were unaffected by HD or IDE (data not
shown) yet there was a significant decrease in the percentage of
CD142+ MP (C) between 100 and 160 min of HD (main effect for
HD, *P < 0.05), irrespective of exercise. All n = 11.
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groups studying EC-derived MP, the dynamics, stimuli
and mechanisms of EC MP formation are little under-
stood (Curtis et al. 2013). It is thought that EC-derived
MP account for a very minor proportion of all circulating
MP (Trappenburg et al. 2012); indeed, they have been
described as “rare” (Tushuizen et al. 2011). While it
might be expected that these MP would increase in num-
ber during HD because of shear stresses and endothelial
activation, the decrease or absence found here and by
other groups may be due to the restoration of viscosity
and laminar shear stress during HD (Amabile et al. 2005)
as high-flux filtration has been shown to reduce the num-
ber of EC-derived MP (Ramirez et al. 2007).
MP effectively act as a storage pool of bioactive effec-
tors (Hugel et al. 2005) and are known to induce EC
ROS (Holtom et al. 2011). Here, we were able to detect
ROS produced when EC were incubated with MP col-
lected up to 60 min after exercise, but not with MP
derived from the end of HD or from any MP samples
taken when these patients were resting during HD. While
endothelial ROS act as important second messengers
within the cells, an imbalance between ROS generation
and innate antioxidant defences represents the primary
cause of endothelial dysfunction and the initiation of vas-
cular diseases (Chen et al. 2018). The consequences of
sustained increases in EC ROS production include the
recruitment of inflammatory cells, proinflammatory cyto-
kine release, reduced nitric oxide vasodilatory activity,
enhanced formation of the deleterious radical, peroxyni-
trite and cell death (El Assar et al. 2013; Barhoumi et al.
2014). However, here the effect was short-lived (<2 h).
Acute, transient proinflammatory events lasting only a
few hours are a key stimulus for longer-term adaptations
to regular exercise that are associated with reduced CVD
risk (Gleeson et al. 2011). In support of this, mouse EC
subjected to laminar shear stress exhibited enhanced
NADPH oxidase subunit expression which was reduced
after 2 weeks of moderate intensity aerobic training
(Robinson et al. 2017) and EPO-enhanced ROS
0
50
100A
B
C
0
50
100
0
50
100
PS
+ 
C
D
42
b+
 M
P 
(%
)
PS
+ 
C
D
14
+ 
M
P 
(%
)
PS
+ 
C
D
66
b+
 M
P 
(%
)
* *
*
60
 m
in
 in
to
 H
D
/p
re
-E
X
/p
os
t-E
X
10
0'
 in
to
 H
D
/6
0 
m
in
 p
os
t-E
x
16
0'
 in
to
 H
D
en
d 
of
 H
D
60
 m
in
 in
to
 H
D
/p
re
-E
X
/p
os
t-E
X
10
0'
 in
to
 H
D
/6
0 
m
in
 p
os
t-E
x
16
0'
 in
to
 H
D
en
d 
of
 H
D
60
 m
in
 in
to
 H
D
/p
re
-E
X
/p
os
t-E
X
10
0'
 in
to
 H
D
/6
0 
m
in
 p
os
t-E
x
16
0'
 in
to
 H
D
en
d 
of
 H
D
Figure 4. Procoagulant phenotypic microparticles over the course
of HD in exercising and non-exercising CKD patients. Patients on
HD rested (open symbols) or exercised (closed symbols). MP isolated
from platelet-free plasma samples were taken 60 min into HD,
immediately following exercise (or equivalent time in control
group), 60 min after exercise (equivalent to 160 min into dialysis
for control group) and at the end of HD and stained with
AnnexinV-FITC and PE-conjugated phenotyping antibodies to
determine presence of phosphatidylserine (PS) and cellular origin,
and analyzed using flow cytometry. Procoagulant PS + MP derived
from platelets (CD42b+) (A) and monocytes (CD14 + ) (B) were
unaffected by HD or IDE. The % PS+ neutrophil-derived MP (C)
decreased 1.8-fold between 100 min (triangles; 43.3  28.4%)
and 160 min into HD (squares; 24.2  25.4%) (*P < 0.05). IDE
had no effect on these responses. All n = 11.
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generation and monocyte/macrophage infiltration were
alleviated after 8 weeks of moderate intensity aerobic
exercise in mice with endothelin-1 overexpression (Bar-
houmi et al. 2014). Furthermore, enhanced in vivo
NADPH oxidase-derived ROS production from EC in the
muscle microvasculature was attenuated after 8 weeks of
moderate intensity aerobic training in sedentary obese
populations (La Favor et al. 2016). The transient, yet
enhanced, ROS production from EC cultured with post-
exercise MP could reflect an initial stimulus for this posi-
tive adaptive process but it must be acknowledged that
the small sample size does not allow definitive conclu-
sions to be made.
Given the pragmatic approach of this study some lim-
itations must be acknowledged. The randomized-cross-
over design allows direct comparisons to be made
between the two trial arms and reduces the potential
impact of confounding elements such as circadian
rhythm. The sample size precludes definitive conclusions
from being made but does provide crucial data to
inform the design of future investigations. Patients eligi-
ble to take part in exercise were healthier with a lower
risk of complications and while the first sample was
taken before exercise, this was 60 min into HD. This
was to allow for patient stabilization and to avoid inter-
ference of routine HD set-up, but it is certainly possible
that increases in MP occurred in that first hour. How-
ever, the purpose of this study was to determine the
effects of an acute session of IDE on MP responses, not
the effects of HD per se. Furthermore, although patients
involved in this study had been taking part in the IDE
program for at least 3 months, this was not a
longitudinal study. The longer-term effects of IDE on
MP responses are still unknown. However, a recent
study in renal transplant recipients reported no changes
in circulating phosphatidylserine+MP after 6 months of
aerobic training yet observed a significant increase in
prothrombotic MP in non-exercising recipients, perhaps
indicating an adaptive amelioration of vascular activation
in the exercising group (Pitha et al. 2015).
In summary, given the known inflammatory proper-
ties of MP these novel findings indicate that an acute
session of moderate intensity IDE does not add further
to the heavy inflammatory burden of HD, extending our
previous findings (Dungey et al. 2015). However, acute
proinflammatory responses to exercise are an avenue for
the development of a longer term anti-inflammatory
adaptation (Gleeson et al. 2011). The ability of MP col-
lected immediately and 60 min after exercise (but not
later than this) to induce a transient amplification of EC
ROS production in vitro may indicate the potential for
a longer-term positive adaptive effect of regular IDE on
endothelial cell function. Given the exceptionally high
risk of CVD in these patients, these novel findings pro-
vide an evidence-base for future study of the long-term
effects of regular IDE on MP phenotype and prothrom-
botic properties.
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